Comparisons of the chemical and biologic properties of triaziquone and triaziquone-protein conjugates.
Prepared with nonimmunospecific proteins were covalent conjugates of triaziquone [2,3,4-tris(1-aziridinyl)-p-benzoquinone] (hereafter referred to by the tradename, Trenimon). The bound Trenimon that absorbs maximally at 350 nm (epsilon = 8,200) was assayed by titration of the acid uptake during alkylation of thiosulfate ion and by the color produced during alkylation of 4-(p-nitrobenzyl)pyridine. Conjugates of Trenimon with nonimmune IgG were toxic to cells in culture, although no firm binding of conjugate to cell surface could be measured by fluorescein labeling. Inhibition of cellular pinocytotic activity with cytochalasin B had no effect on the cytotoxic response. Polyoma virus-transformed baby hamster kidney (BHK) cells that were threefold more resistant to the action of a conjugate than was the parent cell line were as sensitive as normal BHK cells when grown in the presence of dibutyryl cyclic AMP or when acted on in suspension by the conjugate. These conditions did not affect the response of the parent BHK line. Cysteine acted to protect both cell lines. The results suggest that Trenimon bound to nonimmmune protein reacted primarily with a component of the cell surface. The reaction did not appear to depend on a firm attachment of the conjugate to the cell.
D003994:Bucladesine / Q000494:pharmacology; D002462:Cell Membrane / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects*; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured; D055598:Chemical Phenomena; D002621:Chemistry; D003545:Cysteine / Q000494:pharmacology; D008223:Lymphoma / Q000188:drug therapy; D009374:Neoplasms, Experimental / Q000188:drug therapy; D010084:Oxidation-Reduction; D011120:Polyomavirus; D014228:Triaziquone / Q000031:analogs & derivatives* / Q000494:pharmacology*; D005719:gamma-Globulins
D005719:gamma-Globulins; D003994:Bucladesine; D014228:Triaziquone; D003545:Cysteine